AstraZeneca auto-injector pen Fasenra for asthma treatment gets USFDA green light Farhat Nasim4 Oct 2019 1:42 PM ISTFasenra self-administration and the Fasenra Pen are already approved in the European Union and the drug is part of AstraZeneca’s newer class of...
Gilead Descovy wins USFDA approval for preventing sexually acquired HIV infection Medical Dialogues Bureau4 Oct 2019 12:46 PM ISTDescovy, a combination drug, was approved in 2016 to treat people already infected with HIV. It contains a newer formulation of a drug used in Gilead...
Alembic JV Aleor Derma gets USFDA nod for therapeutic equivalent of Clobex Spray Farhat Nasim4 Oct 2019 12:40 PM ISTClobetasol Propionate Spray, 0.05% is indicated for the treatment of moderate to severe plaque psoriasis affecting up to 20% body surface area (BSA)...
Chennai-based Shield Healthcare acquires Brio Bliss Life Science, Nutri Synapzz Medical Dialogues Bureau4 Oct 2019 9:15 AM ISTShield Healthcare said pharmaceuticals and healthcare-focused private equity firm, Fulcrum Venture would also hold significant stake post the...
Bristol-Myers CEO says Japan restrictive drug price policies risk diverting investment Medical Dialogues Bureau4 Oct 2019 9:00 AM ISTJapan is also a major centre for pharma research, producing drugs such as Opdivo, a blockbuster cancer drug licensed globally by Bristol-Myers.TOKYO:...
Zydus announces positive results from EVIDENCES IV Phase 2 clinical trial of Saroglitazar Magnesium in NAFLD and NASH Medical Dialogues Bureau3 Oct 2019 4:35 PM ISTZydus Cadila recently announced that Saroglitazar Magnesium has achieved the primary end-points in the EVIDENCES IV trial in patients with NAFLD and...
Roche presents positive Phase III results for Tecentriq Medical Dialogues Bureau3 Oct 2019 4:17 PM ISTRoche has recently presented positive results from the Phase III IMvigor130 study evaluating Tecentriq® (atezolizumab) plus platinum-based...
Sreeji Gopinathan joins Lupin as Chief Information Officer Medical Dialogues Bureau3 Oct 2019 4:03 PM ISTMumbai, October 03, 2019: Pharma major Lupin Limited announced today the appointment of Sreeji Gopinathan as Chief Information Officer (CIO). He will...
Biocon, Mylan launch insulin biosimilar Semglee in Australia Medical Dialogues Bureau3 Oct 2019 3:51 PM ISTNew Delhi: Biotechnology major Biocon and pharmaceutical company Mylan N V on Thursday announced the launch of their insulin biosimilar Semglee,...
JnJ to pay $20.4 million to settle opioid lawsuits with two Ohio counties Medical Dialogues Bureau3 Oct 2019 9:28 AM ISTJohnson & Johnson said on Tuesday it will pay $20.4 million to settle claims by two Ohio counties in a lawsuit that accused the drugmaker of...
Sub-committee to align Drugs And Cosmetics, Magical Remedies Act to regulate Medical Advertisements: CDSCO Committee Farhat Nasim2 Oct 2019 11:48 AM ISTNew Delhi: The Drug Consultative Committee (DCC), functional under the apex drug regulatory body, Central Drug Standard Control Organisation (CDSCO)...
Lupin clears Japanese regulator PMDA inspection of Goa facility Farhat Nasim2 Oct 2019 9:50 AM ISTThe Pharmaceutical and Medical Devices Agency (PMDA), Japan, has completed the Good Manufacturing Practice inspection of the company's Goa facility...
